Detalhe da pesquisa
1.
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
N Engl J Med
; 382(1): 41-50, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31751012
2.
Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer.
BMC Cancer
; 22(1): 963, 2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36076157
3.
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(2): 113-125, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29151359
4.
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines.
BMC Health Serv Res
; 19(1): 874, 2019 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31752849
5.
Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
J Clin Lab Anal
; 32(1)2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28393405
6.
ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy.
World J Surg Oncol
; 14: 139, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27142166
7.
A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors.
Invest New Drugs
; 33(1): 225-32, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25371323
8.
Targeted therapies in development for non-small cell lung cancer.
J Carcinog
; 12: 22, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24574860
9.
Impact of Waiting Times on Mortality in Advanced Stage Non-Small Cell Lung Cancer: A 10-Year Retrospective Cohort Study in Thailand.
Asian Pac J Cancer Prev
; 24(10): 3419-3428, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898846
10.
Clinical correlations with EGFR circulating tumor DNA testing in all-stage lung adenocarcinoma.
Cancer Biomark
; 36(1): 71-82, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36530081
11.
Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients.
Front Oncol
; 13: 1047644, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895484
12.
CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients.
Front Pharmacol
; 14: 1222435, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38026963
13.
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies.
Target Oncol
; 18(1): 9-24, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652172
14.
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia.
J Thorac Oncol
; 18(4): 436-446, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379356
15.
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301.
J Clin Oncol
; 41(26): 4208-4217, 2023 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379502
16.
Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301.
J Thorac Oncol
; 18(10): 1351-1361, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702629
17.
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study).
Cancers (Basel)
; 15(20)2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37894366
18.
Extracellular Vesicles from EGFR T790M/L858R-mutant Non-small Cell Lung Cancer Promote Cancer Progression.
Anticancer Res
; 42(8): 3835-3844, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35896267
19.
Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients.
Front Oncol
; 12: 916650, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35912215
20.
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations.
Clin Lung Cancer
; 23(8): 670-685, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151006